Translate
Vir Biotechnology, Inc.
About
Vir Biotechnology, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 6 2026
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 5 2026
Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference
Apr 23 2026
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
Apr 16 2026
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
Apr 13 2026
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
Recent Videos
Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech Turnarounds
Apr 27, 2026
Vir Biotechnology Inc. 2025 annual report
Mar 06, 2026
Vir Bio's Cancer Treatment Progress Driving Shares Hight | Bloomberg Businessweek
Mar 02, 2026
UPWARD MOMENTUM | VIR STOCK ANALYSIS | VIR BIOTECHNOLOGY STOCK
Feb 26, 2026